bpc 157 joe rogan gary brecka Peptide Therapy 101: Can BPC-157 & Thymosin Beta-4 Accelerate Ortho-Recovery? bpc 157 degenerative disc disease

The new Shockwave Therapy is a great addition to the PRP

Some data are vendor-claims rather than peer-reviewed stability studies

A 2003 study by Staresinic, Sebecic, Patrlj, and colleagues in Journal of Orthopaedic Research used a rat Achilles tendon transection model with BPC-157 administered intraperitoneally once daily at 10 g/kg, 10 ng/kg, or 10 pg/kg and reported improved load-to-failure, Young's modulus of elasticity, and Achilles functional index scores, reduced tendon defect size by day 14, and increased tendocyte outgrowth in vitro with specific numerical effect sizes and p-values not reported in the abstract

PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinsons disease

This is understandable, as the field continues to prioritize data from double-blind, placebo-controlled, randomized, controlled trials (RCTs) as the benchmark for therapeutic adoption